|
Name |
Acaciicolinol D
|
| Molecular Formula | C15H24O3 | |
| IUPAC Name* |
(2S,4S,6S)-9-(hydroxymethyl)-5,5-dimethyl-1-methylidenespiro[5.5]undec-9-ene-2,4-diol
|
|
| SMILES |
CC1([C@H](C[C@@H](C(=C)[C@]12CCC(=CC2)CO)O)O)C
|
|
| InChI |
InChI=1S/C15H24O3/c1-10-12(17)8-13(18)14(2,3)15(10)6-4-11(9-16)5-7-15/h4,12-13,16-18H,1,5-9H2,2-3H3/t12-,13-,15-/m0/s1
|
|
| InChIKey |
KYEPXJWFBINNCW-YDHLFZDLSA-N
|
|
| Synonyms |
Acaciicolinol D
|
|
| CAS | NA | |
| PubChem CID | 139590763 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 252.35 | ALogp: | 1.0 |
| HBD: | 3 | HBA: | 3 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 60.7 | Aromatic Rings: | 2 |
| Heavy Atoms: | 18 | QED Weighted: | 0.628 |
| Caco-2 Permeability: | -4.643 | MDCK Permeability: | 0.00000766 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.891 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.992 |
| 30% Bioavailability (F30%): | 0.995 |
| Blood-Brain-Barrier Penetration (BBB): | 0.12 | Plasma Protein Binding (PPB): | 29.43% |
| Volume Distribution (VD): | 0.899 | Fu: | 78.88% |
| CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.102 |
| CYP2C19-inhibitor: | 0.012 | CYP2C19-substrate: | 0.711 |
| CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.114 |
| CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.084 |
| CYP3A4-inhibitor: | 0.023 | CYP3A4-substrate: | 0.219 |
| Clearance (CL): | 6.977 | Half-life (T1/2): | 0.49 |
| hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.341 |
| Drug-inuced Liver Injury (DILI): | 0.071 | AMES Toxicity: | 0.032 |
| Rat Oral Acute Toxicity: | 0.944 | Maximum Recommended Daily Dose: | 0.986 |
| Skin Sensitization: | 0.464 | Carcinogencity: | 0.957 |
| Eye Corrosion: | 0.06 | Eye Irritation: | 0.207 |
| Respiratory Toxicity: | 0.987 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003905 | ![]() |
0.655 | D04VIS | ![]() |
0.303 | ||
| ENC003909 | ![]() |
0.500 | D03BLF | ![]() |
0.255 | ||
| ENC003906 | ![]() |
0.477 | D0R7JT | ![]() |
0.247 | ||
| ENC003913 | ![]() |
0.463 | D0CW1P | ![]() |
0.242 | ||
| ENC003911 | ![]() |
0.455 | D0IT2G | ![]() |
0.242 | ||
| ENC003904 | ![]() |
0.433 | D07DVK | ![]() |
0.242 | ||
| ENC005118 | ![]() |
0.412 | D0D1SG | ![]() |
0.240 | ||
| ENC003907 | ![]() |
0.371 | D0KR5B | ![]() |
0.240 | ||
| ENC003908 | ![]() |
0.371 | D0S0NK | ![]() |
0.235 | ||
| ENC003912 | ![]() |
0.371 | D0V9DZ | ![]() |
0.235 | ||